ACHC
Acadia Healthcare Company Inc
27.80$
-2.5%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 12.3% | 6.9% | 7.1% | 7.3% | 7.3% | 7.9% | 38.8% | 10.4% | 10.1% | 11.1% | 9.7% | 14.7% | |
| 4.2% | 0.3% | 0.9% | 1.0% | 0.8% | 1.4% | 5.8% | 2.8% | 2.0% | 1.9% | 1.3% | 2.4% | |
| 4.2% | 0.3% | 0.9% | 1.0% | 0.8% | 1.4% | 5.8% | 2.8% | 2.0% | 1.9% | 1.3% | 2.4% | |
| 6.1% | 5.6% | 5.2% | 5.4% | 5.2% | 4.7% | 4.6% | 6.4% | 7.1% | 8.0% | 7.1% | 9.9% | |
| 0.9% | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | |
| 48.1% | 39.9% | 44.9% | 47.4% | 50.3% | 46.9% | 25.0% | 40.0% | 41.8% | – | – | – | |
| 36.1% | 49.7% | 44.5% | 42.8% | 38.8% | 30.3% | 32.4% | 46.1% | 44.6% | 41.5% | 38.0% | 23.5% | |
| 1.0% | 1.4% | 1.4% | 1.4% | 1.4% | 1.0% | 1.1% | 1.5% | 1.5% | 1.4% | 1.2% | 1.7% | |
| 60.4% | 60.6% | 64.0% | 60.0% | 62.2% | 63.6% | 70.8% | 45.8% | 41.8% | 46.1% | 46.4% | 61.3% | |
| 7.5% | 6.8% | 5.7% | 5.9% | 6.7% | 6.7% | 20.1% | 8.5% | 7.8% | 16.5% | 9.7% | 9.5% | |
| 1.2% | 2.4% | 0.6% | 0.5% | 0.6% | 1.0% | 3.1% | 0.9% | 1.0% | 1.1% | 1.7% | 0.9% | |
| 2.2% | 2.1% | 1.3% | 1.6% | 1.9% | 1.3% | 1.4% | 2.1% | 2.1% | 2.9% | 3.9% | 2.7% | |
| 48.1% | 51.2% | 54.0% | 49.9% | 51.2% | 45.1% | 45.7% | 31.0% | 27.4% | 25.1% | 31.6% | 44.7% | |
| 39.6% | 39.4% | 36.0% | 40.0% | 37.8% | 36.4% | 29.2% | 52.8% | 56.4% | 51.9% | 51.6% | 35.3% | |
| 4.6% | 5.2% | 3.7% | 6.7% | 4.1% | 5.3% | -4.8% | -2.5% | 3.1% | 2.5% | 6.5% | -13.9% | |
| 2.5% | 1.6% | 1.4% | 1.4% | 1.4% | 1.3% | 1.4% | 1.9% | 1.8% | 1.7% | 1.5% | 1.6% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.